U.S. Food And Drug Administration - McKnight's Long Term Care News

U.S. Food And Drug Administration

Alzheimer’s scan clears advisory committee

An advisory committee to the U.S. Food and Drug Administration voted unanimously Thursday that the FDA should approve a brain scan that can identify the beta amyloid plaques that characterize Alzheimer’s in living persons. The FDA typically follows the advice of the advisory committee.

Next post in News